Transcatheter Aortic Valve Replacement (TAVR) – Pipeline Products by Stage of Development 16
Transcatheter Aortic Valve Replacement (TAVR) – Pipeline Products by Territory 17
Transcatheter Aortic Valve Replacement (TAVR) – Pipeline Products by Regulatory Path 18
Transcatheter Aortic Valve Replacement (TAVR) – Pipeline Products by Estimated Approval Date 19
Transcatheter Aortic Valve Replacement (TAVR) – Ongoing Clinical Trials 20
Transcatheter Aortic Valve Replacement (TAVR) Companies – Pipeline Products by Stage of Development 21
Transcatheter Aortic Valve Replacement (TAVR) – Pipeline Products by Stage of Development 24
Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 27
pTAo-TAVR – Product Status 27
pTAo-TAVR – Product Description 27
Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
DurAVR THV System – Product Status 28
DurAVR THV System – Product Description 28
Anteris Technologies Ltd – Ongoing Clinical Trials Overview 29
DurAVR THV System – A Pivotal Study to Evaluate the Efficacy of DurAVR THV System for the Treatment Aortic Stenosis 30
DurAVR THV System – DurAVR THV System in a Valve-in-Valve Procedure: A First Successful Implantation in Humans 30
DurAVR THV System – DurAVR THV System: European Early Feasibility Study 30
DurAVR THV System – Use of DurAVR THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study 30
DurAVR THV System – Use of DurAVR THV System in Subjects with Severe Aortic Stenosis: First In Human Study 31
AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
AorTx Valve – Product Status 32
AorTx Valve – Product Description 32
Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Trilogy Aortic Valve System – Product Status 33
Trilogy Aortic Valve System – Product Description 33
Atlas Medical Pipeline Products & Ongoing Clinical Trials Overview 34
Endurance Valve – Product Status 34
Endurance Valve – Product Description 34
Beijing Balance Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
Renatus – Product Status 35
Renatus – Product Description 35
Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 36
BIOVALVE Resheathable Transcatheter Aortic Valve – Product Status 36
BIOVALVE Resheathable Transcatheter Aortic Valve – Product Description 36
Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 37
ACURATE neo2 Transfemoral TAVR System – Product Status 37
ACURATE neo2 Transfemoral TAVR System – Product Description 38
Gen 4 Lotus Valve System – Product Status 38
Gen 4 Lotus Valve System – Product Description 38
Lotus Edge Sheath 15F – Product Status 39
Lotus Edge Sheath 15F – Product Description 39
Lotus Edge Valve System – 21mm – Product Status 39
Lotus Edge Valve System – 21mm – Product Description 40
Lotus Edge Valve System – 29mm – Product Status 40
Lotus Edge Valve System – 29mm – Product Description 41
LOTUS Mantra – Product Status 41
LOTUS Mantra – Product Description 41
NG ACURATE – Product Status 42
NG ACURATE – Product Description 42
Boston Scientific Corp – Ongoing Clinical Trials Overview 43
ACURATE neo2 Transfemoral TAVR System – ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects Indicated for TAVR 44
ACURATE neo2 Transfemoral TAVR System – ACURATE neo2 Post Market Clinical Follow up Study 44
ACURATE neo2 Transfemoral TAVR System – Project to Look for Early Discharge in Patients Undergoing TAVI With ACURATE – An International Multi-center Early Discharge TAVI Program 44
ACURATE neo2 Transfemoral TAVR System – Prospective Evaluation Complementing Investigation with Acurate Neo Device 45
ACURATE neo2 Transfemoral TAVR System – Prospective, Randomized, Cost-utility Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Brazil 45
ACURATE neo2 Transfemoral TAVR System – PROVE ACURATE neo2 – Post Market Safety and Performance Surveillance in Aortic Stenosis 45
ACURATE neo2 Transfemoral TAVR System – Randomized Study Comparing Both Latest Generation Self-expanding Valves and Local Anesthesia Vs. Conscious Sedation in Transcatheter Aortic Valve Implantation 46
ACURATE neo2 Transfemoral TAVR System – The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis 46
Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Pillar 3D Printed Replacement Heart Valve – Product Status 47
Pillar 3D Printed Replacement Heart Valve – Product Description 47
Chengdu Silara Meditech Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Transcatheter Aortic Valve System – Product Status 48
Transcatheter Aortic Valve System – Product Description 48
Chengdu Silara Meditech Inc – Ongoing Clinical Trials Overview 49
Transcatheter Aortic Valve System – A Prospective, Multi-center, Single-arm Clinical Trial to Evaluate the Safety and Effectiveness of Transcatheter Aortic Valve System in Patients with Severe Aortic Stenosis with or without Moderate or Lower Degree Regurgitation 50
Transcatheter Aortic Valve System – A Prospective, Multicenter, Single-arm Target-value Clinical Trial To Evaluate the Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis 50
Transcatheter Aortic Valve System – To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Symptomatic Aortic Insufficiency 50
Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 51
Colibri TAVI System – Product Status 51
Colibri TAVI System – Product Description 51
Delta Aortic Heart Valve – Product Status 52
Delta Aortic Heart Valve – Product Description 52
Second-Generation TAVI System – Product Status 52
Second-Generation TAVI System – Product Description 53
Venibri Transcatheter Heart Valve System – Product Status 53
Venibri Transcatheter Heart Valve System – Product Description 53
Colibri Heart Valve LLC – Ongoing Clinical Trials Overview 54
Colibri TAVI System – A Prospective, Single Arm Clinical Investigation Evaluating Safety and Performance of the Colibri Transcatheter Aortic Heart Valve System for the Treatment of Symptomatic Severe Aortic Stenosis Via Transfemoral Access in High Surgical Risk Patients 55
ContiTech (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
Balloon-Expandable Transcatheter Aortic Valve Replacement Device – Product Status 56
Balloon-Expandable Transcatheter Aortic Valve Replacement Device – Product Description 56
Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 57
Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) – Product Status 57
Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) – Product Description 57
Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58
18F Direct Flow Medical Transcatheter Aortic Valve System – Product Status 58
18F Direct Flow Medical Transcatheter Aortic Valve System – Product Description 58
22F Percutaneous Aortic Valve System – Product Status 59
22F Percutaneous Aortic Valve System – Product Description 59
Dongguan Tiantianxiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
TAVR – Cardiovascular – Product Status 60
TAVR – Cardiovascular – Product Description 60
DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview 61
Dyneema Purity – Transcatheter Heart Valve – Product Status 61
Dyneema Purity – Transcatheter Heart Valve – Product Description 61
Dura LLC Pipeline Products & Ongoing Clinical Trials Overview 62
LowPro Valve – Product Status 62
LowPro Valve – Product Description 62
Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 63
Next Gen CENTERA – Product Status 63
Next Gen CENTERA – Product Description 63
SAPIEN 3 THV – Asymptomatic Severe Aortic Stenosis – Product Status 64
SAPIEN 3 THV – Asymptomatic Severe Aortic Stenosis – Product Description 64
SAPIEN 3 THV – Moderate Aortic Stenosis – Product Status 64
SAPIEN 3 THV – Moderate Aortic Stenosis – Product Description 65
SAPIEN X4 – Product Status 65
SAPIEN X4 – Product Description 65
Edwards Lifesciences Corp – Ongoing Clinical Trials Overview 66
SAPIEN 3 THV – Moderate Aortic Stenosis – Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advanced Heart Failure: A Randomized Trial (TAVR UNLOAD) 67
SAPIEN 3 THV – Asymptomatic Severe Aortic Stenosis – Risk of Coronary Obstruction Due to Sinus Sequestration by Redo Transcatheter Aortic Valve Implantation in Japanese Patients with SAPIEN 3 68
SAPIEN X4 – Prospective, Single Arm, Multicentre, Feasibility Study to Demonstrate the Safety and Functionality of the Edwards 12f Sheath Introducer Set In Conjunction with the Sapien X4 Transcatheter Heart Valve (THV) In Subjects with Symptomatic, Severe, Calcific Aortic Stenosis (AS) (Protocol Number: 2023-06) 69
SAPIEN X4 – Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve 69
SAPIEN X4 – Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve – Mitral 69
Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview 70
Balloon Expandable Paniagua Heart Valve – Product Status 70
Balloon Expandable Paniagua Heart Valve – Product Description 70
Florida International University Pipeline Products & Ongoing Clinical Trials Overview 71
Percutaneous Aortic Heart Valve – Product Status 71
Percutaneous Aortic Heart Valve – Product Description 71
Folda LLC Pipeline Products & Ongoing Clinical Trials Overview 72
Foldavalve – Product Status 72
Foldavalve – Product Description 72
Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Tria Transcatheter Aortic Valve Replacement Device – Product Status 73
Tria Transcatheter Aortic Valve Replacement Device – Product Description 73
HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
Meridian II Transcatheter Aortic Valve Replacement System – Product Status 74
Meridian II Transcatheter Aortic Valve Replacement System – Product Description 74
HLT, Inc. – Ongoing Clinical Trials Overview 75
Meridian II Transcatheter Aortic Valve Replacement System – Study to Evaluate the Safety and Performance of HLT Meridian TAVR Valve System in the Treatment of Aortic Regurgitation 76
Meridian II Transcatheter Aortic Valve Replacement System – Study to Evaluate the Safety and Performance of HLT Meridian TAVR Valve System in the Treatment of Aortic Stenosis 76
JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
J-Valve TAVI System – Transapical – Product Status 77
J-Valve TAVI System – Transapical – Product Description 77
J-Valve TF System – Product Status 78
J-Valve TF System – Product Description 78
JC Medical, Inc. – Ongoing Clinical Trials Overview 79
J-Valve TF System – J-Valve Compassionate Use Cases 80
J-Valve TF System – J-Valve TF Early Feasibility Study 80
J-Valve TF System – J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy 80
JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 81
JenaValve Pericardial TAVR System – Product Status 81
JenaValve Pericardial TAVR System – Product Description 81
Trilogy Heart Valve System – Product Status 82
Trilogy Heart Valve System – Product Description 82
JenaValve Technology GmbH – Ongoing Clinical Trials Overview 83
JenaValve Pericardial TAVR System – A Study to Assess Safety and Effectiveness of the JenaValve Trilogy Heart Valve System in the Treatment of High Surgical Risk Patients with Symptomatic, Severe Aortic Regurgitation (AR) 84
JenaValve Pericardial TAVR System – THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Regurgitation (AR) 84
Trilogy Heart Valve System – A Prospective, Multicenter, Single-group Clinical Study to Evaluate the Safety and Efficacy of Peijia Medical Transcatheter Aortic Valve System in the Treatment of Severe Aortic Valve Regurgitation 85
Trilogy Heart Valve System – Trilogy Heart Valve System for Management of Patients with Aortic Valve Disease: Patient Registry and Post-market Clinical Follow-up Study 85
Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 86
Ken-Valve – Product Status 86
Ken-Valve – Product Description 86
KenFlex – Product Status 87
KenFlex – Product Description 87
Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 88
Transcatheter Aortic Valve Replacement Device – Product Status 88
Transcatheter Aortic Valve Replacement Device – Product Description 88
KOKA Lifesciences Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
Koka Valve – Product Status 89
Koka Valve – Product Description 89
KOKA Lifesciences Co Ltd – Ongoing Clinical Trials Overview 90
Koka Valve – A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis 91
Laguna Tech USA Inc Pipeline Products & Ongoing Clinical Trials Overview 92
Alpha Self-Expanding Aortic Valve system – Product Status 92
Alpha Self-Expanding Aortic Valve system – Product Description 92
Zeta Balloon Expandable Aortic Valve System – Product Status 93
Zeta Balloon Expandable Aortic Valve System – Product Description 93
Laguna Tech USA Inc – Ongoing Clinical Trials Overview 94
Zeta Balloon Expandable Aortic Valve System – First-in-Human Clinical Study of Zeta Balloon Expandable Aortic Valve System in Patients at High Surgical Risk With Severe Aortic Regurgitation 95
Alpha Self-Expanding Aortic Valve system – First-in-Human Clinical Trial of Alpha Transcatheter Aortic Valve Replacement (TAVR) System for the Treatment of Aortic Regurgitation 96
Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 97
Sinocrown Transcatheter Aortic Valve Replacement System – Product Status 97
Sinocrown Transcatheter Aortic Valve Replacement System – Product Description 97
Transcatheter Aortic Valve Replacement System – Product Status 98
Transcatheter Aortic Valve Replacement System – Product Description 98
Transcatheter Aortic Valve System (Balloon Dilation) – Product Status 98
Transcatheter Aortic Valve System (Balloon Dilation) – Product Description 98
Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 99
Percutaneous Aortic Valve – Product Status 99
Percutaneous Aortic Valve – Product Description 99
Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 100
Evolut Next Gen – Product Status 100
Evolut Next Gen – Product Description 100
Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 101
MyVal S/Ex – Product Status 101
MyVal S/Ex – Product Description 101
MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview 102
VitaFlow Balloon Expandable – Product Status 102
VitaFlow Balloon Expandable – Product Description 102
VitaFlow III – Product Status 103
VitaFlow III – Product Description 103
VitaFlow Novo Generation – Product Status 103
VitaFlow Novo Generation – Product Description 104
Nanjing Saint Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 105
Transcatheter Aortic Valve System – Product Status 105
Transcatheter Aortic Valve System – Product Description 105
Xcor – Product Status 106
Xcor – Product Description 106
Nanjing Saint Medical Technology Co Ltd – Ongoing Clinical Trials Overview 107
Transcatheter Aortic Valve System – To Evaluate the Efficacy and Safety of Transcatheter Aortic Valve System in the Treatment of Severe Aortic Valve Stenosis 108
NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109
Prizvalve II TAVR Valve – Product Status 109
Prizvalve II TAVR Valve – Product Description 109
Prizvalve Pro TAVR Valve – Product Status 110
Prizvalve Pro TAVR Valve – Product Description 110
Prizvalve System – Product Status 110
Prizvalve System – Product Description 111
Starr-A TAVR Valve – Product Status 111
Starr-A TAVR Valve – Product Description 111
NewMed Medical Co Ltd – Ongoing Clinical Trials Overview 112
Prizvalve System – An Exploratory Study to Evaluate the Prizvalve System in Patients With Failing Bioprosthetic Valve 113
Prizvalve System – An Exploratory Study to Evaluate the Prizvalve System in Patients with Severe Atrioventricular Annular Calcification or Failed Prosthetic Atrioventricular Valve/ Annulus Repair 113
Prizvalve System – Evaluation of the Efficacy and Safety of the Transcatheter Aortic Valve Replacement System in Patients with Severe Aortic Valve Stenosis Disease at High Surgical Risk 113
Prizvalve Pro TAVR Valve – Evaluation of the Safety and Efficacy of the Prizvalve Pro Transcatheter Aortic Valve System in the Treatment of Patients With Severe Aortic Valve Stenosis Disease at High Surgical Risk 114
Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 115
Wisefix System – Transcatheter Aortic Valve Implantation – Product Status 115
Wisefix System – Transcatheter Aortic Valve Implantation – Product Description 115
NVT GmbH Pipeline Products & Ongoing Clinical Trials Overview 116
ALLEGRA Plus Transcatheter Heart Valve (THV) System – Product Status 116
ALLEGRA Plus Transcatheter Heart Valve (THV) System – Product Description 116
NVT GmbH – Ongoing Clinical Trials Overview 117
ALLEGRA Plus Transcatheter Heart Valve (THV) System – Investigation of the Safety and Performance of the NVT ALLEGRA Plus THV System in Patients With Severe aortic Stenosis or Failed surgical Aortic bioprosthesis 118
P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview 119
Vienna Aortic Self-Expandable Transcatheter Valve – Product Status 119
Vienna Aortic Self-Expandable Transcatheter Valve – Product Description 119
P+F Products + Features GmbH – Ongoing Clinical Trials Overview 120
Vienna Aortic Self-Expandable Transcatheter Valve – A Two -Stage First in Human (FIH) Feasibility / Pivotal Study of the Vienna Aortic Valve SE System 121
Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 122
Fully Synthetic Transcatheter Valve – Product Status 122
Fully Synthetic Transcatheter Valve – Product Description 122
Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 123
Peijia Balloon Expandable Valve – Product Status 123
Peijia Balloon Expandable Valve – Product Description 123
TaurusApex Polymer Leaflets TAVR System – Product Status 124
TaurusApex Polymer Leaflets TAVR System – Product Description 124
TaurusNXT – Product Status 124
TaurusNXT – Product Description 125
Peijia Medical Ltd – Ongoing Clinical Trials Overview 126
TaurusNXT – A Multi-center, Prospective Study to Evaluate the Safety and Efficacy of TaurusNXT TAVR System for Treating Calcific Severe Aortic Stenosis 127
PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 128
Trileaflet Polymeric Prosthetic Heart Valve – Product Status 128
Trileaflet Polymeric Prosthetic Heart Valve – Product Description 128
RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 129
Synthetic Heart Valve – Product Status 129
Synthetic Heart Valve – Product Description 129
ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview 130
Removable Transcatheter Aortic Valve – Product Status 130
Removable Transcatheter Aortic Valve – Product Description 130
SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 131
Cormove Percutaneous Aortic Valve – Product Status 131
Cormove Percutaneous Aortic Valve – Product Description 131
Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 132
HanchorValve – Product Status 132
HanchorValve – Product Description 132
Transcatheter Aortic Valve Replacement Device – Product Status 133
Transcatheter Aortic Valve Replacement Device – Product Description 133
Shanghai Healing Medical Instruments Co Ltd – Ongoing Clinical Trials Overview 134
HanchorValve – A Multi-center Clinical Study of HanchorValve to Treat Patients with Severe Aortic Regurgitation 135
St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 136
Portico Next Generation Transcatheter Aortic Heart Valve – Product Status 136
Portico Next Generation Transcatheter Aortic Heart Valve – Product Description 136
St. Jude Medical LLC – Ongoing Clinical Trials Overview 137
Portico Next Generation Transcatheter Aortic Heart Valve – Evaluation of the Portico NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis 138
Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 139
Next Generation TAVR Valve – Product Status 139
Next Generation TAVR Valve – Product Description 139
Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 140
SAT TAVI System – Product Status 140
SAT TAVI System – Product Description 140
Suzhou Jiecheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 141
Jiecheng Transvascular Interventional Biological Aortic Valve – Product Status 141
Jiecheng Transvascular Interventional Biological Aortic Valve – Product Description 141
Symetis SA Pipeline Products & Ongoing Clinical Trials Overview 142
ACURATE Prime – Product Status 142
ACURATE Prime – Product Description 142
ACURATE Prime XL Transfemoral Aortic Valve System – Product Status 143
ACURATE Prime XL Transfemoral Aortic Valve System – Product Description 143
ACURATE TAo – Product Status 143
ACURATE TAo – Product Description 144
The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 145
Biomaterial Heart Valve – Product Status 145
Biomaterial Heart Valve – Product Description 145
Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 146
Optimum TAVI System – Product Status 146
Optimum TAVI System – Product Description 146
Thubrikar Aortic Valve, Inc. – Ongoing Clinical Trials Overview 147
Optimum TAVI System – A First-in-human Study to Access Feasibility and Safety of the Optimum Aortic Valve Implant 148
Optimum TAVI System – Efficacy and Safety of Optimum TAVI System in Subjects with Severe Aortic Stenosis: A First-in-Human Study 148
University College London Pipeline Products & Ongoing Clinical Trials Overview 149
TRISKELE Aortic Valve – Product Status 149
TRISKELE Aortic Valve – Product Description 149
University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 150
Transcatheter Aortic Valve – Product Status 150
Transcatheter Aortic Valve – Product Description 150
University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 151
Removable Transcatheter Valve – Product Status 151
Removable Transcatheter Valve – Product Description 151
University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 152
Cellulose Based Aortic Heart Valve – Product Status 152
Cellulose Based Aortic Heart Valve – Product Description 152
University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 153
Aortic Repair Device – Product Status 153
Aortic Repair Device – Product Description 153
Valve Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 154
Xemed TAVR Device – Product Status 154
Xemed TAVR Device – Product Description 154
Valve Medical Ltd. – Ongoing Clinical Trials Overview 155
Xemed TAVR Device – First in Human Study of the GEMINUS Transcatheter Aortic Valve Implantation System in Patients with Severe Symptomatic Aortic Stenosis 156
Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 157
TAVI (Transcatheter Aortic Valve Replacement) – Product Status 157
TAVI (Transcatheter Aortic Valve Replacement) – Product Description 157
Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 158
AR Valve – Product Status 158
AR Valve – Product Description 158
Transapical Trinity Aortic Valve Implantation System – Product Status 159
Transapical Trinity Aortic Valve Implantation System – Product Description 159
Transfemoral Trinity Aortic Valve Implantation System – Product Status 159
Transfemoral Trinity Aortic Valve Implantation System – Product Description 160
Venus PowerX Valve – Product Status 160
Venus PowerX Valve – Product Description 160
Venus Vitae Valve – Product Status 161
Venus Vitae Valve – Product Description 161
Venus Medtech Hangzhou Inc – Ongoing Clinical Trials Overview 162
Venus Vitae Valve – A First-in-man Clinical Trial of Venus Vitae Valve in Patients with Heart Valvular 163
Disease 163
Venus Vitae Valve – Multicenter Pivotal Study to Evaluate the Treatment of Severe Aortic Valve Stenosis With Next-Generation Venus-Vitae Transcatheter Heart Valve (THV) System 163
Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 164
Transcatheter Aortic Heart Valve – Product Status 164
Transcatheter Aortic Heart Valve – Product Description 164
Youngheartvalve LLC Pipeline Products & Ongoing Clinical Trials Overview 165
Polymeric Trans-Catheter Aortic Valve – Product Status 165
Polymeric Trans-Catheter Aortic Valve – Product Description 165
Glossary 199
Buy the Full Report for More Company Insights into the TAVR Pipeline Market
